. 2013 Sep 15;40(11):1025–1035. doi: 10.1111/jcpe.12155

Table 6.

Mean (±standard deviation) for microbiological outcome measures in supragingival plaque

Species	Time point	Mean log10 cfu/ml ± SD			Δ mean log10 cfu/ml
		SRP	SRP + P	p-value	SRP	SRP +P	p-value
Aggregatibacter actinomycetemcomitans	Baseline	3.43 ± 2.29	3.58 ± 3.32	NS
	3 weeks	0.62 ± 1.63^*	0.79 ± 2.13^*	NS	−3.52 ± 1.27	−4.64 ± 2.19	NS
	6 weeks	0.63 ± 1.7^*	1.4 ± 2.56^*	NS	−3.49 ± 1.36	−3.62 ± 2.01	NS
	9 weeks	1.04 ± 1.94^*	1.65 ± 2.85^*	NS	−2.99 ± 1.2	−3.21 ± 2.19	NS
	12 weeks	1.21 ± 2.08^*	2.18 ± 2.83^*	NS	−2.78 ± 1.4	−2.32 ± 1.48	NS
Fusobacterium nucleatum	Baseline	7.12 ± 1.32	6.45 ± 1.66	NS
	3 weeks	1.7 ± 2.49^*	1.14 ± 2.02^*	NS	−5.42 ± 2.21	−5.3 ± 1.6	NS
	6 weeks	3.11 ± 2.69^*	2.99 ± 2.47^*	NS	−4.01 ± 2.41	−3.45 ± 1.42	NS
	9 weeks	4.17 ± 2.62^*	3.82 ± 2.39^*	NS	−2.94 ± 2.31	−2.63 ± 1.19	NS
	12 weeks	5.47 ± 1.71^*	4.48 ± 2.32^*	NS	−1.65 ± 1.2	−1.96 ± 1.19	NS
Porphyromonas gingivalis	Baseline	6.93 ± 1.61	7.17 ± 1.48	NS
	3 weeks	3.97 ± 1.68^*	3.49 ± 1.58^*	NS	−2.97 ± 1.68	−3.68 ± 1.2	0.089
	6 weeks	4.72 ± 1.79^*	4.62 ± 1.22^*	NS	−2.21 ± 1.48	−2.55 ± 1	NS
	9 weeks	5.53 ± 1.9^*	4.9 ± 1.31^*	NS	−1.4 ± 0.82	−2.27 ± 0.84	0.009
	12 weeks	6.05 ± 2.04^*	5.06 ± 1.5^*	NS	−0.89 ± 0.67	−2.11 ± 0.84	0.000
Prevotella intermedia	Baseline	7.64 ± 1.56	6.77 ± 2.45	NS
	3 weeks	3.04 ± 2.24^*	2.79 ± 2.19^*	NS	−4.6 ± 2.03	−4.26 ± 1.65	NS
	6 weeks	4.32 ± 2.16^*	3.28 ± 2.28^*	NS	−3.32 ± 1.7	−3.73 ± 1.69	NS
	9 weeks	4.93 ± 2.41^*	4.22 ± 1.91^*	NS	−2.71 ± 1.93	−2.73 ± 1	NS
	12 weeks	6.08 ± 1.54^*	4.85 ± 1.86^*	0.074	−1.56 ± 1.15	−2.05 ± 0.81	0.085
Tannerella forsythia	Baseline	7.25 ± 0.68	6.89 ± 0.56	NS
	3 weeks	1.49 ± 2.18^*	2.28 ± 2.38^*	NS	−5.76 ± 2.01	−4.61 ± 2.17	NS
	6 weeks	3.58 ± 2.34^*	4.23 ± 1.94^*	NS	−3.67 ± 2.41	−2.67 ± 1.56	NS
	9 weeks	4.68 ± 2^*	4.61 ± 1.99^*	NS	−2.57 ± 1.91	−2.28 ± 1.67	NS
	12 weeks	5.74 ± 1.25^*	5.42 ± 1.27^*	NS	−1.51 ± 1.23	−1.48 ± 1.07	NS
Total load	Baseline	10.56 ± 0.74	10.92 ± 0.72	NS
	3 weeks	8 ± 1.91^*	8.8 ± 1.27^*	NS	−2.55 ± 1.75	−2.12 ± 1.21	NS
	6 weeks	9.15 ± 1.09^*	9.07 ± 1.25^*	NS	−1.41 ± 0.92	−1.85 ± 1.04	NS
	9 weeks	9.51 ± 1.11^*	9.67 ± 1.16^*	NS	−1.04 ± 0.98	−1.26 ± 1.01	NS
	12 weeks	9.89 ± 0.84^*	9.96 ± 0.97^*	NS	−0.66 ± 0.62	−0.97 ± 0.89	NS

Significance of differences between groups; p > 0.1: not significant (NS); p < 0.1 to > 0.05: tendency; p < 0.05: significant (bold).

Significantly different from baseline.

SRP, scaling and rootplaning + placebo lozenge; SRP + P, scaling and rootplaning + probiotic lozenge.